Kerala Ayurveda Ltd is aiming an aggressive push in the US market by launching more standardised products under dietary supplements.
Ramesh Vangal, Chairman of Kerala Ayurveda Ltd, said, "We will introduce 15 products by the end of this fiscal that deals with diabetes, inflammation and weight reduction."
The company has made an investment in Renovel Discoveries in the US for research and validation of ayurvedic formulations.
"The company is exploring the possibility of adapting the ayurvedic medicines for the local community. In India, we have around 800 herbs. But in the US there are only 120. So we need to reorient the system to suit the local population," Vangal said.
Recently, the company tied up with Sanghvi Brands Ltd. Sanghvi is operating luxury spas in the US, West Asia, Sri Lanka and India. Both the companies will together develop and operate ayurvedagram wellness resorts.